CIRS Panel
A deeper biomarker panel for CIRS-pattern illness
The CIRS Health Panel supports a more detailed review when symptoms, history, and exposure suggest a complex inflammatory response.
Listed price
$299 listed
Method
LabCorp blood draw
Results
Typically 2-3 weeks after collection
Availability
Available in most U.S. states except NY, NJ, HI, and RI in the current catalog.
Best fit
Use this test when it can answer the right question.
MoldCo keeps the test lane explicit so a home question, body question, and susceptibility question do not get collapsed into one claim.
People with persistent multi-system symptoms.
Patients who want more than the three-marker Starter Panel.
Cases where inflammation, hormones, and fluid-balance context may affect next steps.
What it measures
- TGF-beta1, MMP-9, and MSH.
- ACTH and cortisol.
- ADH and osmolality.
What it cannot prove
- A standalone CIRS diagnosis.
- A replacement for provider interpretation.
- A panel that includes every marker MoldCo can order, including C4a.
How it works
From order to interpretation
Order through the app after confirming state availability.
Complete the LabCorp blood draw.
Wait for lab processing.
Interpret results alongside symptoms, history, and exposure context.
Before you order
These answers keep the clinical boundary clear: useful context, not a standalone diagnosis.
Does this panel diagnose CIRS?
No. MoldCo treats mold-related illness and uses panels as clinical clues. A diagnosis requires broader clinical context and the right medical evaluation.
Does the CIRS Panel include C4a?
No. C4a is included in the Complete Panel, not the CIRS Panel in the current MoldCo catalog.
Not sure this is the right next step?
Take the Mold Risk Score first, or start care and let a provider help decide whether testing is useful.